Additional Details
-
Assessing Functional Capacity in Directly and Remotely Monitored Home-based Settings: A Protocol for a Multinational Validation Study in Individuals With Chronic Respiratory Diseases
Institut universitaire de cardiologie et de pneumologie de Québec-Université LavalQuébec G1V 4G5 -
Effect of Pulmonary Telerehabilitation and Telemonitoring for Patients With Chronic Respiratory Diseases
University of ManitobaWinnipeg MB. R3E0T6 -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
AccellacareWilmington NC. 28401 -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Paradigm Clinical Research - ReddingRedding CA. 96001 -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Clinical Site PartnersWinter Park FL. 32789 -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Renstar Medical ResearchOcala FL. 34470 -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Southeastern Research CenterWinston-Salem NC. 27103 -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Lowcountry Lung and Critical CareCharleston SC. 29406 -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Newport Native MD, Inc.Newport Beach CA. 92663 -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Clinical Site Partners, LCCLeesburg FL. 34748 -
Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF
Newport Native MD, Inc.Newport Beach CA. 92663 -
Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF
Southeastern Research CenterWinston-Salem NC. 27103 -
Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect
Massachusetts General HospitalBoston MA. 02114 -
Move With Air: Physiological Response Assessment
Centre of Innovative Medicine of the McGill University Health CentreMontreal QC. H4A 3J1 -
Move With Air: Exercise Training Study
Centre of Innovative Medicine of the McGill University Health CentreMontreal QC. H4A 3J1 -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
UCLA Health Westwood Medical PlazaWestwood CA. 90095 -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Arizona Pulmonary SpecialistsPhoenix AZ. 85012 -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Summit HealthBend OR. 97701 -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Vincent Medical GroupIndianapolis IN. 46260 -
Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis
Molecure Investigative SiteKansas City KS. 66062